This page is part of the FHIR Specification v6.0.0-ballot1: Release 6 Ballot (1st Draft) (see Ballot Notes). The current version is 5.0.0. For a full list of available versions, see the Directory of published versions
Example ClinicalUseDefinition/example-interaction (XML)
Raw XML (canonical form + also see XML Format Specification)
Jump past Narrative
Interaction effect example (id = "example-interaction")
<?xml version="1.0" encoding="UTF-8"?>
<ClinicalUseDefinition xmlns="http://hl7.org/fhir">
<id value="example-interaction"/>
<text> <status value="extensions"/> <div xmlns="http://www.w3.org/1999/xhtml"><p> <b> Generated Narrative: ClinicalUseDefinition</b> <a name="example-interaction"> </a> </p> <div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border:
1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ClinicalUseDefinition "example-interaction" </p> </div> <p> <b> StructureDefinition Work Group</b> : brr</p> <p> <b> type</b> : interaction</p> <p> <b> subject</b> : <a href="medicinalproductdefinition-example.html">MedicinalProductDefinition/example</a> </p> <blockquote> <p> <b> interaction</b> </p> <blockquote> <p> <b> interactant</b> </p> <p> <b> item</b> : alphaconazole <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (interactant#alphaconazole)</span> </p> </blockquote> <blockquote> <p> <b> interactant</b> </p> <p> <b> item</b> : betaconazole <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (interactant#betaconazole)</span> </p> </blockquote> <p> <b> type</b> : Inhibitor <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (interactionsType#Inhibitor)</span> </p> <h3> Effects</h3> <table class="grid"><tr> <td style="display: none">-</td> <td> <b> Concept</b> </td> </tr> <tr> <td style="display: none">*</td> <td> Increased plasma concentration <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> ()</span> </td> </tr> </table> <p> <b> management</b> : Careful monitoring of dose <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> ()</span> </p> </blockquote> </div> </text> <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg"><valueCode value="brr"/> </extension>
<publisher value="HL7 International / Biomedical Research and Regulation"/>
<contact>
<telecom>
<system value="url"/>
</telecom>
</contact>
<type value="interaction"/>
<subject>
<reference value="MedicinalProductDefinition/example"/>
</subject>
<interaction>
<interactant>
<itemCodeableConcept>
<coding>
<system value="http://ema.europa.eu/example/interactant"/>
<code value="alphaconazole"/>
</coding>
</itemCodeableConcept>
</interactant>
<interactant>
<itemCodeableConcept>
<coding>
<system value="http://ema.europa.eu/example/interactant"/>
<code value="betaconazole"/>
</coding>
</itemCodeableConcept>
</interactant>
<type>
<coding>
<system value="http://ema.europa.eu/example/interactionsType"/>
<code value="Inhibitor"/>
</coding>
</type>
<effect>
<concept>
<text value="Increased plasma concentration"/>
</concept>
</effect>
<management>
<text value="Careful monitoring of dose"/>
</management>
</interaction>
</ClinicalUseDefinition>
Usage note: every effort has been made to ensure that the
examples are correct and useful, but they are not a normative part
of the specification.